2018. First experience in Switzerland in Phe508del homozygous cystic fibrosis patients with end-stage pulmonary disease enrolled in a lumacaftor-ivacaftor therapy trial – preliminary results. Swiss Medical Weekly. 148, 0708 (Feb. 2018), w14593. DOI:https://doi.org/10.4414/smw.2018.14593.